BACKGROUND: Counseling in family dementia care aims to support caregivers in mastering challenges. The use of information and communication technologies (ICT) to administer counseling can improve accessibility. Evidence syntheses report inconsistent ...
BACKGROUND: Undiagnosed cognitive impairment poses a global challenge, prompting recent interest in ultra-brief screening questionnaires (comprising <2 to 3 items) to efficiently identify individuals needing further evaluation. However, evidence on u...
Dementia is among the most distressing and burdensome health challenges in aging populations. Treatment efficacy is limited; however, early diagnosis can delay or prevent disease progression. Previous machine learning-based prediction models have lim...
BACKGROUND: People with dementia commonly display behavioral and psychological symptoms, which have multiple negative consequences. Artificial intelligence-based technologies (AITs) have the potential to support earlier detection of the behavioral an...
British journal of hospital medicine (London, England : 2005)
Oct 9, 2025
Dementia poses major challenges to healthcare worldwide. Traditional diagnostics rely on lengthy assessments, and access to specialist clinicians is limited. Large language models (LLMs), like Generative Pre-trained Transformer 4 (GPT-4) present new ...
BACKGROUND: Financial hardship (including financial stress, financial strain, asset depletion, and financial toxicity) is a highly relevant construct among the 6.9 million people living with Alzheimer's disease and related dementias (ADRD) in the Uni...
BACKGROUND: The aim of the study is to develop a machine learning (ML) model to identify contributing factors to dementia-related safety events using patient safety event report data.
INTRODUCTION: Dementia caregiving is typically provided through a network of multiple individuals, particularly in diverse populations. Although family members of people living with Alzheimer's disease and Alzheimer's disease-related dementias, espec...
BACKGROUND: The Inflation Reduction Act (IRA) did not introduce a cap on out-of-pocket (OOP) for newly approved Alzheimer's Disease (AD) drugs, such as lecanemab which is covered under Medicare Part B. Therefore, expanding the use of conventional ant...
Alzheimer's disease (AD) poses significant challenges for the elderly, leading to cognitive decline, social isolation, and lower quality of life. Current interventions often require cumbersome wearable devices e.g. the camera-based monitoring that ma...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.